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HYDROPS FETALIS ASSOCIATED WITH HOMOZYGOSITY 
FOR Hb ADANA [a59(E8)Gly®Asp (a2)]
Hydrops Fetalis and Homozygosity For Hb Adana I.M. Nainggolan et al. Ita M. Nainggolan, Alida Harahap, and Iswari Setianingsih
The Eijkman Institute for Molecular Biology, Jakarta, Indonesia
 We describe cases of hydrops fetalis associated with nondeletional a-thalassemia (a-thal), in
three unrelated Indonesian families. The genotypes of the fetuses and their parents were generated by
DNA sequencing and by a polymerase chain reaction restriction fragment length polymorphism
(PCR-RFLP)-based method to rapidly identify mutations detected by sequencing. Two of the fetuses
had hydrops fetalis and homozygous a59(E8)Gly®Asp (a2), also known as Hb Adana. The third
fetus was also suspected to be homozygous for Hb Adana because both parents were carriers of this
mutation. This study shows that homozygosity for Hb Adana is associated with hydrops fetalis in
the Indonesian population. We discuss this mutation and its various phenotypes including com-
pound heterozygosity with other a-thal mutations and describe a simple approach to genetic testing
that will clarify the risk of hydrops fetalis in the offspring of couples carrying this nondeletional
mutation.
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Molecular diagnosis
In Southeast Asia, homozygosity for Southeast Asian-type α0-thalassemia
(α0-thal), (– –SEA/– –SEA) is the most common cause of hydrops fetalis (1-3).
This paper examines three cases of hydrops fetalis in Indonesian fetuses
homozygous for the HBA2:c.179G>A mutation (also known as Hb Adana or
the αcodon 59α/αcodon 59α genotype); one mother was a compound heterozy-
gote for the Hb Adana mutation and a “silent” mutation at codon 22 of the
α2 gene [α22(B3)Gly→Gly or HBA2:c.69C>T; also known as the αcodon
59α/αcodon 22α genotype] and she manisfested a moderate α-thal. The
codon 59 mutation is also known as Hb Adana and was first described on
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the α1-globin gene [α59(E8)Gly→Asp (α1)] in two Turkish patients (4).
The same mutation was subsequently found on the α2-globin gene
[α59(E8)Gly→Asp (α2)] in an Albanian patient (5).
Two sets of parents carrying hydrops fetalis fetuses in a current preg-
nancy and one set with a previous history of hydrops fetalis were referred to
the GenNeka Clinic (Yayasan GenNeka, Eijkman Institute for Molecular
Biology, Jakarta, Indonesia) for genetic evaluation and counseling. All are
ethnically Javanese.
Two cases of hydrops fetalis were diagnosed by ultrasonography. Com-
plete blood counts (Cell Dyne 1700; Abbot Diagnostics, Abbott Park, IL,
USA), erythrocyte morphology examination by microscope and hemoglo-
bin (Hb) analysis by high performance liquid chromatography (HPLC) on
a VARIANT™ Hemoglobin Testing System (β-Thalassemia Short Program;
Bio-Rad Laboratories, Hercules, CA, USA) (6) were performed for all
fathers, mothers and available newborn babies as well as affected fetuses.
We did not assess the iron status of all individuals. II-1 (Family 1) and II-1
(Family 2) were delivered at the gestational ages of 22 weeks and 21 weeks,
respectively. Cordocentesis was performed on both II-1 (Family 1) and
II-1 (Family 2), who died after delivery; prenatal diagnosis was performed
on II-2 (Family 1) and II-1, II-2 and II-3 (Family 2). The pedigrees are
shown in Figure 1. To eliminate maternal cell contamination in the pre-
natal diagnosis, DNA from the parents and the fetuses was fingerprinted
for variable number tandem repeat (VNTR) D1S80 and apolipoprotein B
(APO-B), (7,8).
DNA was extracted from peripheral blood leukocytes from all six par-
ents and from the cord blood of II-1 and II-2 (Family 1), II-1, II-2 and II-3
(Family 2). DNA was isolated using a modification of the Puregene DNA
isolation method (Gentra Systems Inc., Minneapolis, MN, USA). DNA from
amniocytes was isolated using a salting-out method adapted from Miller et
al. (9). For all parents, DNA analysis consisted of multiplex polymerase
chain reaction (m-PCR) for α0-thal deletions including the Southeast Asian,
Filipino, and Thai types (10). Multiplex PCR for α0-thal types was negative
for all family members. Direct DNA sequencing of the whole α2- and α1-
globin genes was performed using the BigDye Dideoxy Terminator
sequencing kit v3.1 (Applied Biosystems, Foster City, CA, USA) on an ABI
PRISM™ 3130 automated sequencing (Applied Biosystems). DNA sequencing
carried out on the parents in Family 1 and the mother in Family 2 (I-2),
showed that they were all heterozygous for Hb Adana on the α2-globin
gene. Then we developed a direct mutation detection system using a PCR-
RFLP (restriction fragment length polymorphism) method. Since there is
no restriction site that can differentiate between the normal and mutant
alleles, we developed an ACRS (amplified created restriction site) method
to directly detect the codon 59 (α2) mutation. The forward primer, codon396 I.M. Nainggolan et al.
59modF, was a modified primer where T (thymine) was used to introduce a
recognition sequence for the Taq-αI restriction enzyme in the mutant allele.
The forward and reverse primers, codon 59modF (5′-GCT CTG CCC AGG
TTA AGG GCC TCG-3′) and α2R (5′-GGG AGG CCC ATC GGG CAG GAG
GAA C-3′) (11), were used to amplify a 460 bp fragment (GenBank,
NG_000006). The PCR reaction mixture (25 μL) contained 100 ng DNA,
10 μM of each primer, 200 μM dNTPs, 1X PCR buffer and 1.25 units of Taq
DNA polymerase (New England Biolabs, Beverly, MA, USA). Reactions
were carried out in a PE 9700 thermocycler (Perkin Elmer Applied Biosys-
tems, Foster City, CA, USA) with an initial denaturation of 5 min. at 95°C
followed by 35 cycles at 95°C for 30 seconds, 68°C for 30 seconds and 72°C
for 1 min and one cycle at 72°C for 5 mins. The PCR product was digested
using Taq-αI restriction enzyme (New England Biolabs) and visualized
under UV light (Gel Doc; Bio-Rad Laboratories). Figure 2 shows an exam-
ple of gel electrophoresis of the PCR-RFLP products. The PCR-RFLP analy-
sis for this mutation showed all parents were heterozygous for Hb Adana
(α2) and DNA sequencing on both α2- and α1-globin genes confirmed that
the PCR-RFLP method correctly identified the genotypes (data not shown).
In addition, DNA sequencing of I-2 (Family 2) showed that she also carried
a synonymous α22(B3)Gly→Gly (α2) in trans allele as well as the codon 59
FIGURE 1 Pedigrees and genotypes of the three family members. *Presumed genotype based on
parental genotypes; N/A = not available.
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(α2) mutation. The α22(B3)Gly→Gly (α2) is predicted to produce an abnor-
mal splice donor site between codons 22 and 23 (GGTGAG) leading to a
premature termination between codons 48 and 49 (12). I-2 (Family 2), who is
a compound heterozygote for both these mutations, shows a more severe
phenotype compared to those with only Hb Adana (α2). This result provides
evidence that the α22(B3)Gly→Gly (α2) is indeed a thalassemia allele.
The II-1 (Family 1) and II-1 (Family 2) fetuses were homozygous for the
Hb Adana (α2) mutation. II-1 (Family 3) was delivered dead at 25 weeks
gestation and samples were not obtained. Given the parental genotypes, the
death of the fetus was assumed to be due to homozygosity for Hb Adana
(α2). The II-1 (Family 1) and II-1 (Family 2) fetuses, who were homozygous
for Hb Adana (α2), produced peaks on the HPL chromatogram that corre-
sponded with Hb Bart’s (γ4), Hb H (β4), Hb A (α2β2) and Hb F (α2γ2)
(13,14). Hematological data for all cases are shown in Table 1.
I-2 (Family 1) and I-2 (Family 2), with different genotypes, both showed
Hb levels lower than normal during pregnancy, however, I-2 (Family 1)
never required blood transfusions, whereas I-2 (Family 2) always required
blood transfusion 4 to 5 times during each pregnancy. We do not know the
cause of the mild anemia of I-2 (Family 1) because we did not assess the
iron level. The other mother, I-2 (Family 3), had blood drawn for hemato-
logical examination 1 month after she had received a blood transfusion for
postpartum hemorrhage after delivering a hydrops fetalis fetus and showed
a normal Hb level of 13.6 g/dL. The clinical manifestation of individuals
who are heterozygous for Hb Adana (α2) during pregnancy in these cases is
still unclear. The clinical manifestations of the Hb Adana carriers in gen-
eral are within normal limits, with normal Hb levels and slightly reduced
MCV and MCH levels as shown in Table 1.
FIGURE 2 Gel electrophoresis of the PCR-RFLP products from Family 1.
M U1 2 3
M: φx 174/HaeIII
U: uncut PCR product
1: normal control for α2 codon 59
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The cases in this study are of interest because fetuses with the αcodon 59α/
αcodon 59α genotype all manifest as hydrops fetalis although they still have
two functional α-globin genes. Moreover, the clinical manifestations of
these hydrops fetalis fetuses were more severe (miscarried at 22, 21 and 25
weeks gestation) than those of fetuses with the – –SEA/– –SEA or αcodon 59α/–
– genotype, who died at about 33 weeks (range 23–43 weeks) (15) and at
28–29 weeks gestational age, respectively (16,17). Interestingly, the com-
pound heterozygote for Hb Adana on the α1-globin gene and α0-thal did
not manifest as hydrops fetalis but severe hemolytic anemia which required
regular blood transfusion from an early age (4,18). This might be caused by
the higher rate of the α2-globin gene transcription than the α1-globin gene
that resulted in the higher amount of variant α-globin chain or unstable
variant Hb. Although we still do not know the mechanism of hydrops fetalis
in a fetus with the codon 59 (α2) homozygosity, because they still have two
intact α-globin genes on chromosome 16, it appears that the severity of the
phenotype might not be due to the decreased α-globin chains synthesis but
the variant α-globin chains interfere with normal tetramer formation or
damage erythrocytes in some other way. It has also been suggested that this
unstable Hb variant has a defect in the detoxification process by α-Hb stabi-
lizing protein (19). Therefore, the higher amount of variant α-globin chain
or unstable variant Hb will result in a more severe phenotype. Further research
is required to elucidate how this mutation causes hydrops fetalis. Hydrops
fetalis due to other non deletional α-thalassemias (homozygosity for α-globin
variants has been previously reported) (20,21), however it was unclear whether
it was the α-thal alone which caused hydrops fetalis in both cases.
While reports of Hb Adana (α2 or α1) from other countries are limited,
in our Clinic, the recent frequency of this mutation seems high (16%) in
Indonesian α-thal patients with clinically manifested thalassemia interme-
dia and thalassemia major including hydrops fetalis cases (unpublished
data). Our previous population study (14), based on hematology parame-
ters found the carrier frequency of α0- and α+-thal in the Indonesian popu-
lation to be around 2.6–3.2% and 2.7–11%, respectively. DNA analysis
limited to large α-globin gene deletions (two and one α-globin gene),
showed that the frequency of the 3.7 kb deletion was around 0.5–2%, and
that of the 4.2 kb deletion about 0.2%. We found that the frequency of the
Hb Adana (α2) mutation is quite high (14). The possibility of a high fre-
quency of the Hb Adana (α2) mutation in Indonesians and the severe phe-
notype of this mutation in the homozygous state is a very important issue in
the prevention and management program of thalassemia in Indonesia.
Moreover, most Hb Adana carriers are asymptomatic or exhibit only mild
anemia, with red cell indices quite similar to those of α+-thal carriers due to
one α-globin gene deletion (14). Therefore, molecular diagnosis should be
proposed as a routine diagnosis for all suspected α-thal carriers. For this400 I.M. Nainggolan et al.
purpose, the PCR-RFLP method that has been developed can be used as a
less expensive and faster method.
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